SARS-CoV-2 Spike and Neutralizing Antibody Kinetics 90 Days after Three Doses of BNT162b2 mRNA COVID-19 Vaccine in Singapore

Background: We evaluated the post-booster (BNT162b2) antibody responses in Singapore. Methods: Participants (n = 43) were tested pre-booster and 20/30/60/90 days post-booster. Participants were boosted 120–240 days (mean 214 days) after their second dose and had no history or serologic evidence of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Chin Shern, Phua, Soon Kieng, Liang, Ya Li, Oh, May Lin Helen, Aw, Tar Choon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879250/
https://www.ncbi.nlm.nih.gov/pubmed/35214789
http://dx.doi.org/10.3390/vaccines10020331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879250/
https://www.ncbi.nlm.nih.gov/pubmed/35214789
http://dx.doi.org/10.3390/vaccines10020331

Ejemplares similares